2017 POC/Point-of-Care Infectious Disease Testing Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

March 2017 | 835 pages | ID: P4DFAB028CEEN
Venture Planning Group

Abstracts

VPGMarketResearchs new report provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

• Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
• Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
• Physician Offices/Group Practices
• Emergency Rooms
• Ambulatory Care Centers
• Surgery Centers
• Birth Centers

Sales and Market Share Analysis

• Sales and market shares ofmajor reagent and instrument suppliers.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculosis, Vibrio, West Nile, Yersenia.Technology Review

• Emerging technologies and their applications for POC testing.
• Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

• Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
• Design criteria for POC testing products.
• Alternative business expansion strategies.
• Potential market entry barriers and risks.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

The companies analyzed in the report include:

• Abbott
• Accriva
• ADI/American Diagnostica
• Agilent Technologies
• Alere/Biosite/Inverness
• Axis-Shield
• Beckman Coulter/Danaher
• Becton Dickinson
• Bio/Data
• Biomerieux
• Bio-Rad
• Cepheid
• Chrono-Log
• Corgenix
• Decode Genetics
• Diadexus
• Diagnocure
• Diagnostica Stago/Trinity Biotech
• Diamedix/Erba
• Diasorin
• Eiken Chemical
• EKF Diagnostics
• Fujirebio
• Grifols
• Helena Laboratories
• Hologic/Gen-Probe
• Horiba
• Instrumentation Laboratory
• Kreatech/Leica
• Kyowa Medex
• Lonza
• Mackay Life Sciences
• Matritech
• Nihon Kohden
• Ortho-Clinical Diagnostics
• Polartechnics
• Polymedco
• Qiagen
• Roche
• SDIX
• Sequenom
• Siemens
• Sienco
• Sysmex
• Takara Bio
• Thermo Fisher
• Tosoh
• Wako
• Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 835 pages and80 tables

Contents

INTRODUCTION

EXECUTIVE SUMMARY

RATIONALE FOR TESTING DECENTRALIZATION

  1. OVERVIEW
  2. REGULATORY TRENDS
  3. ECONOMIC TRENDS
  4. DEMOGRAPHIC TRENDS
  5. TECHNOLOGICAL TRENDS
  6. SOCIAL TRENDS
  7. QUALITY OF CARE
  8. DEFENSIVE MEDICINE
  9. QUALITY CONTROL ISSUES

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

  1. AIDS
  2. ADENOVIRUS
  3. CAMPYLOBACTER
  4. CANDIDA
  5. CHLAMYDIA
  6. CLOSTRIDIUM DIFFICILE
  7. CYTOMEGALOVIRUS
  8. ENTEROVIRUSES
  9. EPSTEInBARR VIRUS
  10. GONORRHEA
  11. HELICOBACTER PYLORI
  12. HEPATITIS
    a. Hepatitis A
    b. Hepatitis B
    c. Hepatitis C
    d. Hepatitis D
  13. HERPES SIMPLEX VIRUS
  14. HUMAN HERPES VIRUS  6 (HHV  6)
  15. INFLUENZA VIRUSES
  16. LEGIONELLA
  17. LYME DISEASE
  18. MEASLES (RUBEOLA)
  19. MENINGITIS
  20. MONONUCLEOSIS
  21. MUMPS
  22. MYCOPLASMA
  23. PAPILLOMAVIRUSES
  24. PNEUMONIA
  25. RESPIRATORY SYNCYTIAL VIRUS (RSV)
  26. RHEUMATOID ARTHRITIS
  27. ROTAVIRUS (REOVIRUS)
  28. RUBELLA (GERMAN MEASLES)
  29. SALMONELLOSIS
  30. SHIGELLOSIS
  31. STAPHYLOCOCCUS AUREUS
  32. STREPTOCOCCI
  33. SYPHILIS
INSTRUMENTATION: Infectious Disease Analyzers Manufactured by:
  Abbott
  Beckman Coulter/Danaher
  bioMeriuex
  Ortho Clinical Diagnostics
  Roche
  Siemens
  Tosoh
  Wallac, and other suppliers

CURRENT AND EMERGING TECHNOLOGIES

  1. MONOCLONAL ANTIBODIES
  2. IMMUNOASSAYS
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle Membrane Capture Immunoassay
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescent Polarization
      Time Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  3. DRY CHEMISTRY
  4. BIOSENSORS
  5. IT AND AUTOMATION
  6. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
      Ligase Chain Reaction
      Branched DNA
      Q  Beta Replicase
      Strand Displacement Activation
      Self Sustained Sequence Replicase

U.S.A.

    a. MARKET OVERVIEW

  1. BUSINESS ENVIRONMENT
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care

      PPO

      HMO

    f. Hospitals
    g. Admissions
    h. Length of Stay

1. INDUSTRY DIVERSIFICATION

j. Physician Demographics
k. Aging Population
      More Chronic Illness
      Disease Incidence
      Susceptibility t      latrogenesis
      Multiple Illnesses Cases
l. Laboratory Regulations
  2. MARKET STRUCTURE
    a. Hospitals
    b. Commercial/Private Laboratories
    c. Physician Offices/Group Practices
  1. MARKET SUMMARY
  2. MARKET STRUCTURE
  3. TEST VOLUME AND SALES FORECASTS
    d. ANCILLARY HOSPITAL LOCATIONS

  1. INTRODUCTION
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. EMERGENCY DEPARTMENTS
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. OPERATING AND RECOVERY SUITES
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUS/CCUS
    a. Market Summary
    b. Test Volume and Sales Forecasts
    e. Cancer Clinics
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. TEST VOLUME AND SALES FORECASTS
    f. Ambulatory Care Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
    g. Surgery Centers
  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
    h. Nursing Homes 1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS

1. BIRTH CENTERS

  1. INTRODUCTION
  2. MARKET SUMMARY
  3. MARKET STRUCTURE
  4. TEST VOLUME AND SALES FORECASTS
J. Major Suppliers’ Instrument Placements, Installed Base, Reagent Sales and Market Shares
Germany
    a. MARKET OVERVIEW

    b. Market Structure
    c. Market Summary
    d. Major Suppliers’ Reagent Sales and Market Shares
Spain
    a. Business Environment
    b. Market Structure
    c. Market Summary
    d. Major Suppliers’ Reagent Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

    a. Internal Development
    b. Collaborative Arrangements
    c. University Contracts
    d. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    a. Market Maturity
    b. Cost Containment
    c. Competition
    d. Technological Edge and Limitations
    e. Patent Protection
    f. Regulatory Constraints
    g. Decentralized Testing Market Challenges

COMPANY PROFILE

  Abbott
  Affymetrix
  Beckman Coulter/Danaher
  Becton Dickinson
  bioMerieux
  Bio Rad
  Cepheid
  Diamedix
  DiaSorin
  Eiken Chemical
  EnzBiochem
  Fujirebio/Innogenetics
  Grifols/Novartis Diagnostics
  Hologic/GenProbe
  ID Biomedical/GSK
  Kreatech
  Lonza
  Nanogen/Elitech
  Ortho Clinical Diagnostics
  Qiagen
  Roche
  Scienion
  Sequenom
  SeraCare
  Siemens
  Takara Bio
  ThermFisher/Life Technology
  Wallac/PE
  Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
U.S.A., ANCILLARY HOSPITAL LOCATIONS Estimated Number
U.S.A., ANCILLARY HOSPITAL LOCATIONS Annual Utilization
U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
Germany, Laboratory Performing Diagnostic Tests by Market Segment
Germany, AIDS Testing Market Estimated Market Share of Major Suppliers
Germany, Gonorrhea Testing Market Estimated Market Share of Major Suppliers
Germany, Hepatitis Testing Market Estimated Market Share of Major Suppliers
Germany, Herpes Testing Market Estimated Market Share of Major Suppliers
Germany, Influenza Testing Market Estimated Market Share of Major Suppliers
Germany, Mononucleosis Testing Market Estimated Market Share of Major Suppliers
Germany, Septicemia Testing Market Estimated Market Share of Major Suppliers
Germany, Streptococci Testing Market Estimated Market Share of Major Suppliers
Spain, Laboratory Performing INFECTIOUS DISEASE TESTS by Market Segment
Spain, AIDS Testing Market Estimated Market Shares of Major Suppliers
Spain, Chlamydia Testing Market Estimated Market Shares of Major Suppliers
Spain, Hepatitis Testing Market Estimated Market Shares of Major Suppliers
Spain, Herpes Testing Market Estimated Market Shares of Major Suppliers
Spain, Influenza Testing Market Estimated Market Shares of Major Suppliers
Spain, Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
Spain, Rubella Testing Market Estimated Market Shares of Major Suppliers
Spain, Streptococci Testing Market Estimated Market Shares of Major Suppliers
Spain, Syphilis Testing Market Estimated Market Shares of Major Suppliers